Get started
Author

Gisela González

Observed names: Gisela Gonzalez, Gisela González, Gisela González Marinello, Gisela González Marinello, Gisela M Gonzalez Marinello
OpenAlex ID: A5111472294
Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced Non–Small-Cell Lung Cancer
2008 · Elia Neninger Vinageras, Ana de la Torre, et al. · Journal of Clinical Oncology · 194
Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti–Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non–Small-Cell Lung Cancer Patients Treated with the Epidermal Growth Factor Cancer Vaccine
2008 · Beatriz García, Elia Neninger, et al. · Clinical Cancer Research · 119
PDF
Clinical Development and Perspectives of CIMAvax EGF, Cuban Vaccine for Non-small-cell Lung Cancer Therapy
2010 · Pedro C Rodríguez, Gryssell Rodríguez, et al. · MEDICC Review · 89
PDF
Therapeutic Vaccination with Epidermal Growth Factor (EGF) in Advanced Lung Cancer: Analysis of Pooled Data from Three Clinical Trials
2007 · Gisela González, Tania Crombet, et al. · Human Vaccines · 74
PDF
Combining an EGF-based Cancer Vaccine With Chemotherapy in Advanced Nonsmall Cell Lung Cancer
2008 · Elia Neninger, Beatriz García Verdecia, et al. · Journal of Immunotherapy · 62
Treatment of NSCLC patients with an EGF-based cancer vaccine: Report of a phase I trial
2006 · Tania Crombet Ramos, Elia Neninger Vinageras, et al. · Cancer Biology & Therapy · 57
Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
2003 · Agustín Lage, Tania Crombet, et al. · PubMed · 43
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
2011 · Pedro C Rodriguez, Elia Neninger, et al. · Journal of Immune Based Therapies and Vaccines · 32
PDF
Epidermal growth factor vaccine in non-small-cell lung cancer
2012 · Gisela M Gonzalez Marinello, Edgardo S Santos, et al. · Expert Review of Anticancer Therapy · 10
CIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer
2009 · Gisela González, Agustín Lage, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 8
EGF-based cancer vaccine: Optimizing predictive and surrogate biomarkers.
2013 · Tania Crombet Ramos, Elia Neninger, et al. · Journal of Clinical Oncology · 6
Therapeutic vaccination with an EGF-based vaccine in lung cancer: a step in the transition to a chronic disease
2011 · Gryssell Rodriguez, Gisela Gonzalez, et al. · Expert Review of Respiratory Medicine · 6
EGF-based cancer vaccine for advanced NSCLC: Results from a phase III trial.
2012 · Tania Crombet Ramos, Elia Neninger, et al. · Journal of Clinical Oncology · 4
Stratified Cox Regression Analysis of Survival under CIMAvax®EGF Vaccine
2013 · Carmen Viada Gonzalez, Jean-François Dupuy, et al. · Journal of Cancer Therapy · 3
PDF
CIMAvax®EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation
2013 · Carmen Viada Gonzalez, Jean-François Dupuy, et al. · Modern Chemotherapy · 3
PDF
Current Algorithm for Treatment of Advanced NSCLC Patients: How to Include Active Immunotherapy?
2013 · Gisela Gonzalez, Arlhee Diaz-Miqueli, et al. · Journal of Cancer Therapy · 1
PDF
Clinical Development Paradigms for Cancer Vaccines: The Case of CIMAvax EGF®
2011 · Gisela Gonzalez, Tania Crombet, et al. · InTech eBooks · 1
PDF
Innovations in advanced cancer therapy: Therapeutic vaccines for chronic treatments
2013 · Gisela González · Journal of Vaccines & Vaccination
CIMAvaxEGF, an Epidermal Growth Factor (EGF) based cancer vaccine for non small cell lung cancer therapy: Product development and post-marketing experiences
2013 · Gisela González Marinello · Journal of Vaccines & Vaccination
Response to epidermal growth factor vaccine in patients with metastatic non-small cell lung cancer (NSCLC) after progressing to first-line therapy.
2012 · Diego Venegas, Elia Neninger, et al. · Journal of Clinical Oncology
O-153 Results of a phase II trial of EGF-P64 vaccine in patients with
2003 · Mark Vincent, Colum Smith, et al. · Lung Cancer
Works count: 22
Citation count: 712
H-index: 9
I10-index: 9
Year
Topic
Type